References
World Health Organization. International drug monitoring: the role of the hospital. WHO Tech Rep Ser 1969; No. 425
Thürmann PA. Methods and systems to detect adverse drug reactions in hospitals. Drug Saf 2001; 24(13): 961–8
Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9
Evans JMM, MacDonald TM. Record-linkage for pharmacovigilance in Scotland. Br J Clin Pharmacol 1999; 47: 105–10
Currie CJ, MacDonald TM. Use of routine healthcare data in safe and cost-effective drug use. Drug Saf 2000; 22: 97–102
Lau HS, Florax C, Porsius AJ, et al. The completeness of medication histories in hospital medical reports of patients admitted to general internal medicine wards. Br J Clin Pharmacol 2000; 49: 597–603
Schmitt K, Windecker R, Steffen J, et al. Detection of adverse drug reactions by a computer-based generation of laboratory signals [abstract]. Br J Clin Pharmacol 2000 [Abstracts of CPT 2000]; 87: A331
Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301–8
Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61–8
Pouyanne P, Haramburu F, Imbs JL, et al., for the French Pharmacovigilance Centres. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ 2000; 320: 1036
Roughead EE, Gilbert AL, Primrose JG, et al. Drug-related hospital admissions: a review of Australian studies published 1988–1996. Med J Aust 1998; 168: 405–8
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279: 1200–7
Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring — cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admission. Pharmacoepidemiol Drug Saf 1997; 6 (3 Suppl.): S71–7
Imbs JL, Pouyanne P, Haramburu F, et al. Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Thérapie 1999; 54: 21–7
Dormann H, Muth-Selbach U, Krebs S, et al. Incidence and costs of adverse drug reactions during hospitalisation. Drug Saf 2000; 2: 161–8
Hallas J, Harvald B, Worm J, et al. Drug related hospital admissions. Eur J Clin Pharmacol 1993; 45: 199–203
Rights and permissions
About this article
Cite this article
Comprehensive surveillance of adverse drug reactions in hospital provides important data to inform the safe use of drug therapy. Drugs Ther. Perspect 18, 14–16 (2002). https://doi.org/10.2165/00042310-200218120-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200218120-00005